NanoVibronix, Inc.
NAOV
$5.15
-$0.75-12.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -62.28% | -17.90% | 177.89% | 160.17% | 1,253.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -62.28% | -17.90% | 177.89% | 160.17% | 1,253.92% |
| Cost of Revenue | -63.41% | 122.94% | 398.72% | 115.97% | 122.22% |
| Gross Profit | -61.60% | -61.89% | 98.15% | 182.55% | 345.67% |
| SG&A Expenses | 27.93% | -13.39% | -23.11% | -10.04% | -21.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.42% | 19.33% | 14.43% | 5.68% | -5.42% |
| Operating Income | -300.58% | -44.78% | 33.20% | 46.16% | 79.98% |
| Income Before Tax | -77.81% | -37.43% | 35.53% | 46.94% | 61.11% |
| Income Tax Expenses | -54.55% | 0.00% | -69.23% | 250.00% | 466.67% |
| Earnings from Continuing Operations | -76.01% | -37.28% | 35.94% | 46.40% | 60.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.01% | -37.28% | 35.94% | 46.40% | 60.51% |
| EBIT | -300.58% | -44.78% | 33.20% | 46.16% | 79.98% |
| EBITDA | -300.58% | -44.78% | 33.25% | 46.13% | 79.98% |
| EPS Basic | 7.41% | 15.72% | 61.76% | 64.73% | 70.27% |
| Normalized Basic EPS | -69.71% | 15.62% | 61.51% | 65.08% | 80.73% |
| EPS Diluted | 7.41% | 15.72% | 61.76% | 64.73% | 70.27% |
| Normalized Diluted EPS | -69.71% | 15.62% | 61.51% | 65.08% | 80.73% |
| Average Basic Shares Outstanding | 90.09% | 62.81% | 67.50% | 51.93% | 32.79% |
| Average Diluted Shares Outstanding | 90.09% | 62.81% | 67.50% | 51.93% | 32.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |